BCG vaccine immunity against human tuberculosis. The BCG vaccine can be anywhere from 0 to 80% effective in preventing tuberculosis for a duration of 15 years; however, its protective effect appears to vary according to geography and the lab in which the vaccine strain was grown. A number of different companies make BCG, sometimes using different genetic strains of the bacterium. This may result in different product characteristics. OncoTICE, used for bladder instillation for bladder cancer, was developed by Organon Laboratories (since acquired by Schering-Plough, and in turn acquired by Merck & Co.). Pacis BCG, made from the Montréal (Institut Armand-Frappier) strain,
Abell 1201 BCG s within 5 kpc rising to 360 km s at 20 kpc distance. The BCG also acts as a gravitational lens, bending the light of a more distant background galaxy (at redshift 0.451) into an apparent tangential arc about 6 kpc to one side. This makes the galaxy an important case in investigations of the intrinsic properties of dark matter. Detailed models of the lens mass distribution, starlight and stellar kinematics indicates that the galaxy cluster's dark halo has a shallow inner density gradient and perhaps a soft dark matter core. At face value, this is incompatible with the dark